Table 2.

Female Sexual Function Index and Female Sexual Distress Scale Scores of Women with Endometriosis-Associated Pain Symptoms at Baseline and at 3 and 6 Months of 24/4 Regimen 17β-Estradiol (1.5 mg) and Nomegestrol Acetate (2.5 mg) Combined Oral Contraceptive

	Baseline (n = 99)	3rd month follow-up (n = 89)	6th month follow-up (n = 77)	p-value, 3rd month vs. baseline	p-value, 6th month vs. baseline
FSFI score	18.3 ± 1.5	27.5 ± 1.6	30.2 ± 1.8	0.001	0.001
FSDS score	18.5 ± 1.5	13.6 ± 1.7	10.2 ± 1.8	0.001	0.001

Values are mean ± SD.

FSDS, Female Sexual Distress Scale; FSFI, Female Sexual Function Index; SD, standard deviation.